Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02046382 · ClinicalTrials.gov registry record · Phase 4
RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief
A Phase 4 study, sponsored by TriHealth.
- Completed
- Registry status
- Phase 4
- Development phase
- 132
- Enrollment target
NCT02046382 is a Phase 4 study that has completed, run by TriHealth. The registered enrollment target is 132 participants.
The verdict
NCT02046382, a Phase 4 study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 132 participants
- Enrollment target
Study Summary
This study is being done to evaluate the scheduled use of intravenous (IV) acetaminophen among cesarean section patients. The study hopes to find out if patients who receive scheduled IV acetaminophen for 48 hours following delivery have lower self-reported pain scores and use less narcotic pain medication than patients who do not receive IV acetaminophen.
Interventions
- DRUG Placebo
- DRUG IV Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02046382
The ClinicalTrials.gov registry entry for NCT02046382 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02046382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02046382 about?
NCT02046382 is a clinical study titled "RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief". This study is being done to evaluate the scheduled use of intravenous (IV) acetaminophen among cesarean section patients. The study hopes to find out if patients who receive scheduled IV acetaminophen for 48 hours following delivery have lower self-reported pain scores and use less narcotic pain med...
What is the current status of trial NCT02046382?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 132 participants. The study started on 2014-01. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02046382?
The interventions under investigation include: Placebo (DRUG), IV Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02046382?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.